← FDA DRUG APPROVALS

FDA ANDA · ANDA091106

VINORELBINE

Sponsor: JIANGSU HANSOH PHARM

APPLICATION
ANDA091106
TYPE
ANDA
ORIGINAL APPROVAL
2012-09-26
LATEST ACTION
2020-08-20
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VINORELBINE TARTRATEPrescription
VINORELBINE TARTRATE EQ 10MG BASE/ML · INJECTABLE · INJECTION

Approval history

2020-08-20Labeling · Supplement 9 · standardAP
2020-07-27Labeling · Supplement 7 · standardAP
2020-07-27Labeling · Supplement 5 · standardAP
2013-01-09Labeling · Supplement 1 · standardAP
2012-09-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →